A biomarker could help identify patients with lung cancer who are most likely to benefit from treatment with AstraZeneca and Daiichi Sankyo's TROP2-directed drug datopotamab deruxtecan (Dato-DXd).

Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted ...

For many years, ... Feb. 6, 2025 — Scientists have created a new low-cost, fast response sensor to detect lung cancer biomarkers, paving the way for the development of screening devices to spot ...

Treating patients with lung cancer always calls for a focus on informed and shared decision-making, according to expert ...

A biomedical expert and cancer researcher, Esther Ugwueke, has said that Nigeria must urgently invest in advanced technologies like artificial intelligence and bioinformatics to improve cancer ...

Biomarker-targeted adjuvant therapy improved survival in early-stage NSCLC, highlighting the importance of testing and ...

AstraZeneca, Pfizer and more are leveraging the computational power of AI to better design trials, predict the potential ...

Dr. Suresh Ramalingam discusses how Tagrisso has ushered in a new era of care for patients with advanced EGFR+ non-small cell ...

Quest plans to refine, develop and validate the technology and is aiming to launch the test in North America next year.

Artificial intelligence (AI) is entering the mainstream. The term encompasses a wide variety of machines that can learn from ...

A novel immuno-PET/CT imaging technique has identified and validated a potent biomarker for nasopharyngeal cancer (NPC). The biomarker, CD70, is highly and constantly expressed in NPCs, and ...

Cancer cases are on the rise in young people but misdiagnosis remains an issue, with everything from anxiety to menopause ...